Full Text
HTA24 Orphan Drugs: What Is the Impact of Special Provisions in Value Assessment?

Abstract

Authors

M Epstein S Michel

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×